Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Melatonin increases oestrogen receptor binding activity of human breast cancer cells

Abstract

Breast cancer is frequently a hormone-dependent tumour, and several studies have suggested that the pineal gland hormone melatonin may influence the growth and development of this malignancy. Subcutaneous injections of melatonin have been shown to inhibit, and pinealectomy to enhance, the development of dimethyl benz(a)anthracene (DMBA)-induced mammary tumours in rats1. Use of the psychotropic drug thorazine, which increases plasma melatonin levels2, has been associated with a decreased incidence of breast cancer in psychiatric patients3. Calcification of the pineal gland has been correlated with an increased incidence of breast cancer in women4. While the mechanism by which melatonin influences these tumours is unknown, both human breast cancer and DMBA-induced tumours contain oestrogen receptors (ER) and respond to changes in the oestrogen milieu5–7. We therefore wondered whether melatonin might be altering ER binding activity of these tumours. We report here that in vitro incubation of MCF-7 human breast cancer cells with melatonin in physiological conditions increased the cytoplasmic and nuclear ER activity of these cells within 40 min, giving no change in the equilibrium dissociation constant (Kd) of the receptor. This induction was blocked by cycloheximide, and thus requires continuous protein synthesis. The modulation of ER binding activity of breast cancer by another endogenous hormone may be important for understanding the behaviour and treatment of this disease, and may provide insight into the factors regulating the synthesis and metabolism of steroid hormone receptors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tamarkin, L. et al. Cancer Res. 41, 4432–4436 (1981).

    CAS  PubMed  Google Scholar 

  2. Wurtman, R. J. & Axelrod, J. Nature 212, 12–313 (1966).

    Article  Google Scholar 

  3. Brugmans, J., Verbryggen, F., Dom, J. & Schuermans, V. Lancet i, 502–503 (1973).

    Article  Google Scholar 

  4. Cohen, M., Lippman, M. E. & Chabner, B. Lancet i, 814–815 (1978).

    Article  Google Scholar 

  5. Desombre, E. R., Greene, G. L. & Jensen, E. V. in Hormones, Receptors and Breast Cancer (ed. McGuire, W. L.) 1–14 (Raven, New York, 1978).

    Google Scholar 

  6. Asselin, J., Melancon, R., Moachin, G. & Belanger, A. Cancer Res. 40, 1612–1622 (1980).

    CAS  PubMed  Google Scholar 

  7. Huggins, C., Briziarelli, G. & Sutton, H. Jr J. exp. Med. 109, 25–42 (1959).

    Article  CAS  Google Scholar 

  8. Arendt, J., Wetterberg, L., Heyden, T., Sizonenko, P. C. & Paunier, L. Hormone Res. 8, 65–75 (1977).

    Article  CAS  Google Scholar 

  9. Scatchard, G. Ann. N.Y. Acad. Sci. 51, 660–666 (1949).

    Article  ADS  CAS  Google Scholar 

  10. Aitken, S. & Lippman, M. E. J. Steroid Biochem. 8, 77–80 (1977).

    Article  CAS  Google Scholar 

  11. Danforth, D. N. Jr, Tamarkin, L., Do, R. & Lippman, M. E. Endocrinology 113, 81–85 (1983).

    Article  CAS  Google Scholar 

  12. Gibbs, F. P. & Vriend, J. Endocrinology 109, 1796–1798 (1981).

    Article  CAS  Google Scholar 

  13. Horwitz, K. B. & McGuire, W. L. J. biol. Chem. 255, 9699–9705 (1980).

    CAS  PubMed  Google Scholar 

  14. Eckert, R. L., Rorke, E. A. & Katzenellenbogen, W. L. Endocrine Soc. 64th a. Meet. Abstr. 29 (1982).

  15. Zava, D. & McGuire, W. L. J. biol. Chem. 352, 3703–3708 (1977).

    Google Scholar 

  16. Edwards, D. P., Martin, P. M., Horwitz, K. B., Chamness, G. C. & McGuire, W. L. Expl. Cell Res. 127, 197–213 (1980).

    Article  CAS  Google Scholar 

  17. Henderson, C. & Canellos, G. P. New Engl. J. Med. 302, 78–90 (1980).

    Article  CAS  Google Scholar 

  18. Horwitz, K. B., Aiginger, P., Kutten, F. & McGuire, W. L. Endocrinology 108, 1703–1709 (1981).

    Article  CAS  Google Scholar 

  19. Neifeld, J., Lippman, M. E. & Tormey, D. J. biol. Chem. 252, 2972–2977 (1977).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danforth, D., Tamarkin, L. & Lippman, M. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature 305, 323–325 (1983). https://doi.org/10.1038/305323a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/305323a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing